2025-08-21 - Analysis Report
Okay, here's a comprehensive analysis of Hims & Hers Health Inc (HIMS), based on the provided data. The report is structured with key figures first, followed by analysis.

**Report: Hims & Hers Health Inc (HIMS) Analysis**

Hims & Hers Health Inc (HIMS) is a telehealth company that offers personalized healthcare solutions.

**1. Performance vs. S&P 500 (VOO)**

*   **HIMS Cumulative Return:** 252.17%
*   **VOO (S&P 500) Cumulative Return:** 37.28%
*   **Absolute Deviation (Current):** 100.5
*   **Relative Deviation:** 50.1 (This indicates HIMS's outperformance is in the middle of its historical range relative to the S&P 500).
*   **Deviation Range**  (max: 288.9, min: -88.4)

**Alpha and Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha   | Beta   | Cap(B) |
|------------|---------|--------|---------|--------|--------|
| 2019-2021  | 6.0%   | 0.0%   | 6.0%   | -1.8   | 1.5    |
| 2020-2022  | 31.0%   | 72.9%  | 41.0%   | -0.1   | 1.4    |
| 2021-2023  | 34.0%   | 72.9%  | 24.0%   | 0.1    | 2.0    |
| 2022-2024  | 145.0%  | 78.4%  | 116.0%  | 0.2    | 5.5    |
| 2023-2025  | 195.0%  | 80.3%  | 152.0%  | 0.2    | 9.8    |

*   **Analysis:** The company has exhibited high growth (CAGR) in recent periods, but also high volatility (MDD). The strong Alpha values indicate outperformance compared to the market, and Beta values have gradually increased to be closer to market correlation.. This demonstrates the company's ability to generate returns independent of overall market movements, particularly in the most recent periods. Increasing Market Cap, which implies that the company's overall value is growing substantially, especially from 2022 to 2025, suggesting strong investor confidence and market recognition.

**2. Recent Price Action**

*   **Current Price:** $43.38
*   **Previous Close:** $42.18
*   **Change:** 2.84%
*   **5-Day Moving Average:** $44.76
*   **20-Day Moving Average:** $53.56
*   **60-Day Moving Average:** $52.67

*   **Analysis:** The stock price increased compared to previous close. The price is below all moving averages, indicating a potential downtrend or consolidation phase. The significant price increase since the last close ($42.18 to $43.38) may reflect a positive market response to recent news or events.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3316 (Low Risk)
*   **RSI:** 11.12 (Oversold)
*   **PPO:** -2.99 (Negative)
*   **Hybrid Signal:** cash_70%_Sell 0.1% of holdings (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** -2.7 (Negative - Short-term Decline)
*   **Expected Return:** -15.3% (Projected long-term underperformance vs. S&P 500 if investing now)

*   **Analysis:** The low RSI value suggests the stock is oversold and could be due for a bounce.  A negative PPO indicates a bearish trend. The negative change in relative deviation confirms recent underperformance compared to the S&P 500. The hybrid signal recommends reducing holdings, emphasizing caution. Despite low MRI indicating low market risk, the negative expected return suggests caution for new long-term investments.

**4. Recent News & Significant Events**

*   **[2025-08-17]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-18]:** Analyst discussions on recent performance and industry outlook.
*   **[2025-08-19]:** Notable stock volatility influenced by recent news/earnings.
*   **[2025-08-20]:** Market experts highlighting risks and opportunities.

*   **Analysis:** Recent news indicates significant activity around HIMS, including market volatility, analyst scrutiny, and potentially impactful events. Investors should closely monitor news and announcements.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-08-04 | 0.19 | 0.54 B$ |
| 2025-05-05 | 0.22 | 0.59 B$ |
| 2024-11-04 | 0.35 | 0.40 B$ |
| 2024-08-05 | 0.06 | 0.32 B$ |
| 2025-08-04 | 0.06 | 0.32 B$ |

*   **Analysis:** The data shows fluctuating EPS and Revenue figures. While recent revenues are higher compared to previous year (2024-08-05), EPS is slightly lower on the latest earning. A spike in EPS on 2024-11-04. EPS data show a fluctuating performance with no consistent growth trend.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.54B  | 76.39%        |
| 2025-03-31 | $0.59B  | 73.50%        |
| 2024-12-31 | $0.48B  | 76.81%        |
| 2024-09-30 | $0.40B  | 79.16%        |
| 2024-06-30 | $0.32B  | 81.30%        |

**Capital and Profitability**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-06-30 | $0.56B  | 7.55%   |
| 2025-03-31 | $0.55B  | 9.01%   |
| 2024-12-31 | $0.48B  | 5.46%   |
| 2024-09-30 | $0.44B  | 17.18%  |
| 2024-06-30 | $0.36B  | 3.67%   |

*   **Analysis:** Revenue has generally increased over the last year, but profit margins have slightly decreased, from 81.30% to 76.39%. Equity has grown, but ROE has been volatile, with a recent decrease. This could be due to a variety of factors, including increased expenses or changes in asset utilization.

**7. Overall Summary and Recommendation**

*   **Summary:** Hims & Hers Health Inc (HIMS) has significantly outperformed the S&P 500 over the long term, as evidenced by the substantial cumulative return and alpha values. However, recent technical indicators suggest a short-term downtrend, and the negative expected return indicates potential underperformance compared to the S&P 500 if investing at the current price. Recent news suggests increased volatility and potential market-moving events. The company's revenue is growing, but profitability is fluctuating.
*   **Recommendation:** Given the mixed signals, a cautious approach is warranted. **Existing shareholders might consider the hybrid signal's recommendation to reduce holdings slightly.** Potential investors should wait for a clearer indication of a trend reversal or positive catalyst before initiating a new position. Monitoring upcoming news and earnings reports will be crucial. The current negative sentiment and potential downside risk should be carefully considered.

**Disclaimer:** This is an AI-generated analysis based on provided data and should not be considered financial advice. Always conduct thorough research and consult with a qualified financial advisor before making investment decisions.
